VIDEO: Impact of Intellectual Property Aspects of Free Trade Agreements on the Response to COVID-19
Trade agreements have become a very important mechanism for internationally harmonizing intellectual property rules, with profound implications in these times of pandemic both for access to medicines, evidently, and, not least important, regarding restrictions on citizens’ rights in terms of digital rights and copyright. As multilateral negotiations become increasingly complex, lengthy and far-reaching, it is crucial that our community remains informed, engaged, and aware of the important role that it must play.
Based on the experiences in negotiating some of those treaties and on their results, this session will provide an analysis of the technical, political and economic elements at stake, and of the way in which such elements currently influence the global framework of intellectual property debates in different spheres.
Main presentation: Roberto López Linares, Sociologist, Acción Internacional por la Salud – Peru.
Holds an academic degree in sociology. Has participated in community health programs, in various studies and evaluations of health and drug programs, and in information dissemination activities on drugs in relation to their rational use and access. Has experience in the advocacy of universal access to medicines and other health technologies, questioning trade agreements and national laws that establish barriers to such access. Executive Director of International Action for Health (AIS Perú).
Moderator: Claudia Marcela Vargas. Director IFARMA.
Panelists: Viviana Muñoz Tellez, Intellectual Property Expert, South Centre.
Maria Fabiana Jorge is the founder and president of MFJ International, LLC, a global consulting firm specializing in international business, foreign trade, and global government relations. Ms. Jorge received her MBA from Columbia University in 2000 and her BA with honors in 1987 with a Political Science and International Relations degree from the Catholic University in Argentina.
Ms. Jorge, a former trade negotiator, has over 25 years experience in helping companies open international markets and expand globally. She designed and implemented strategies for government affairs operations, trade negotiations and disputes around the world. She is an expert on trade matters related to pharmaceuticals. Her clients are corporations, associations, governments and international organizations.
Ms. Jorge has been involved in intellectual property and access to affordable medicines for 27 years. She has been a strong advocate for striking a balance between the protection of intellectual property rights and ensuring expedited access to affordable medicines for consumers throughout the world. Ms. Jorge has worked in a number of U.S. trade negotiations including FTAA, CAFTA, US-Chile FTA, USAFTA, ACTA, the Trans Pacific Partnership (TPP) the EU-Canada Comprehensive and Trade Agreement (CETA) and NAFTA 2.0. She is currently involved in the Regional Comprehensive Economic Partnership (RCEP) and the EU-Mercosur negotiation. She championed the Doha Amendment in the Trade Promotion Authority (TPA) and played a critical role in the renegotiation of trade agreements with Peru, Colombia and Panama called the New Trade Policy or May 10th Agreement. She was also very involved with the adoption of the biosimilar law in Mexico and other biosimilar issues.
Miguel Ernesto Cortés Gamba, Pharmaceutical Chemist, Master in Administration, Vice President of the National College of Pharmaceutical Chemists of Colombia, CNQFC, Advisor on international reference prices of the United Nations Office of Project Services, UNOPS; Consultant for conducting studies on the impact of intellectual property on the price and access to medicines in several countries in Latin America and the Caribbean.
Colombia
Joan Rovira: Professor Emeritus of the University of Barcelona.
Speakers
-
Roberto López Linares
-
Viviana Muñoz Tellez
-
María Fabiana Jorge
-
Claudia Marcela Vargas
-
Miguel Cortés
-
Joan Rovira
Comments are closed here.